Evidence map›Paper›PMID 24886959›Full record

ArticleVaccine2014

Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations.

Denise M Bruno, Tracey E Wilson, Francesca Gany, Abraham Aragones

4 registry-linked trialsAbstract read
In one paragraph

Article in Vaccine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03510091 nacompletednot on this mapstarted 2018, after this paper: background citation

Video-assisted Counseling for Human Papillomavirus Vaccination: A Pilot Study

TypeinterventionalSponsorLe Bonheur Children's HospitalRan2018 to 2019Enrolled21ConditionsHuman Papillomavirus InfectionArmsCounseling
NCT06290206 nacompletednot on this mapstarted 2024, after this paper: background citation

PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - BootCamp Translation

TypeinterventionalSponsorUniversity of UtahRan2024 to 2024Enrolled18ConditionsHPV Vaccination, Vaccine, Uptake, VaccinationArmsPREVENT - BCT
NCT06738355 nacompletednot on this mapstarted 2025, after this paper: background citation

PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - Pilot Trial

TypeinterventionalSponsorUniversity of UtahRan2025 to 2025Enrolled335ConditionsHPV Vaccination, Uptake Vaccination, Series CompletionArmsPREVENT
NCT07217145 phase3active not recruitingnot on this mapstarted 2025, after this paper: background citation

PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - Randomized Controlled Trial (RCT)

TypeinterventionalSponsorUniversity of UtahRan2025 to 2027Enrolled1,455ConditionsHPV Vaccination, Uptake Vaccination, Series CompletionArmsPREVENT
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Human PapillomaVirus Vaccine Uptake: Attitudes and Practices Among Moroccan Physicians.Journal of cancer education : the official journal of the American Association for Cancer Education · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Provider perspectives on multilevel barriers to HPV vaccination.Human vaccines & immunotherapeutics · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Denise M BrunoDepartment of Community Health Sciences, State University of New York, Downstate Medical Center, School of Public Health, 450 Clarkson Avenue, Mail Stop Code 43, Brooklyn, NY 11203, USA. Electronic address: denise.bruno@downstate.edu.
Tracey E WilsonDepartment of Community Health Sciences, State University of New York, Downstate Medical Center, School of Public Health, 450 Clarkson Avenue, Mail Stop Code 43, Brooklyn, NY 11203, USA. Electronic address: tracey.wilson@downstate.edu.
Francesca GanyImmigrant Health and Cancer Disparities, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA. Electronic address: ganyf@mskcc.org.
Abraham AragonesImmigrant Health and Cancer Disparities, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA. Electronic address: aragonea@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
HPV vaccine practices among Physicians Serving High Risk, Minority PopulationsR03CA144734 · NCI · SUNY DOWNSTATE MEDICAL CENTER · PI ARAGONES, ABRAHAM · 2009 to 2010
$159k
NCI NIH HHS 1R03CA144734NCI NIH HHS P30 CA008748NCI NIH HHS R03 CA144734
6 · The paper itself

Abstract

objectiveMinority populations in the United States are disproportionally affected by human papillomavirus (HPV) infection and HPV-related cancer. We sought to understand physician practices, knowledge and beliefs that affect utilization of the HPV vaccine in primary care settings serving large minority populations in areas with increased rates of HPV-related cancer. STUDY

designCross-sectional survey of randomly selected primary care providers, including pediatricians, family practice physicians and internists, serving large minority populations in Brooklyn, N.Y. and in areas with higher than average cervical cancer rates.

resultsOf 156 physicians randomly selected, 121 eligible providers responded to the survey; 64% were pediatricians, 19% were internists and 17% were family practitioners. Thirty-four percent of respondents reported that they routinely offered HPV vaccine to their eligible patients. Seventy percent of physicians reported that the lack of preventive care visits for patients in the eligible age group limited their ability to recommend the HPV vaccine and 70% of those who reported this barrier do not routinely recommend HPV vaccine. The lack of time to educate parents about the HPV vaccine and cost of the vaccine to their patients were two commonly reported barriers that affected whether providers offered the vaccine.

conclusionsOur study found that the majority of providers serving the highest risk populations for HPV infection and HPV-related cancers are not routinely recommending the HPV vaccine to their patients. Reasons for providers' failure to recommend the HPV vaccine routinely are identified and possible areas for targeted interventions to increase HPV vaccination rates are discussed.

Indexed as

Physicians, Primary CareCross-Sectional StudiesEmigrants and ImmigrantsFemaleHealth Knowledge, Attitudes, PracticeHumansMinority GroupsNew York CityPapillomavirus InfectionsPapillomavirus VaccinesPovertyPractice Patterns, Physicians'Primary Health CareUterine Cervical NeoplasmsVaccinationPapillomavirus VaccinesHPV vaccine and primary care providersHPV vaccine barriersHuman papillomavirus vaccine

Identifiers

PMID24886959
PMCPMC4107630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.